Radioligand therapy with 177lu-psma-i&t in patients with metastatic castration-resistant prostate cancer: oncological outcomes and toxicity profile

JOURNAL OF UROLOGY(2023)

引用 0|浏览7
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要